Faculty & Staff Details

	Name:	Charles F. Seifert, Pharm.D., FCCP, BCPS
	Position:	Professor and Regional Dean, Adult Medicine Division, Lubbock
	Email:	charles.seifert@ttuhsc.edu
	Bio	Dr. Seifert is currently Professor of Pharmacy Practice and Regional Dean for Lubbock Programs. He earned a B.S. in Pharmacy from North Dakota State University in 1982; a Doctor of Pharmacy degree from The University of Texas at Austin and The University of Texas Health Science Center at San Antonio in 1984; and completed an ASHP accredited Residency in Clinical Pharmacy from Truman Medical Center and the University of Missouri-Kansas City from 1984-1985. Dr. Seifert grew up on a ranch near Hettinger, North Dakota. He was an Assistant Professor and then an Associate Professor of Adult Medicine with Tenure in the Section of Pharmacy Practice at The University of Oklahoma Health Sciences Center College of Pharmacy from 1985 to 1994. He was the Director of Clinical Pharmacy Services at Rapid City Regional Hospital in Rapid City, SD from 1994 to January of 1998 when he assumed his present position. He has been married to his wife Cheryl for 30 years, who is an elementary school teacher in the Lubbock Independent School District. He has four beautiful children: Amanda, 28, who is a junior Psychology major at Texas Tech University, Adam, 27, who is a resident at the Lubbock State Supported Living Center, Cole, 22, Ph.D. candidate in Medicinal Chemistry at Texas Tech University, and Brianne, 19, an accomplished English equestrian and a sophomore Mechanical Engineering major at Texas Tech University. He is an accomplished vocalist and is very active in the Celebration Choir at Christ the King Cathedral. He is on the Family Association Board of the Lubbock State Supported Living Center. He enjoys RVing, writing contemporary Christian music, Big XII sports and is a die hard Minnesota Vikings football fan.

Education:

B.S. in Pharmacy, North Dakota State University-1982
Doctor of Pharmacy, University of Texas at Austin & University of Texas Health Science Center at San Antonio-1984
ASHP Accredited Clinical Pharmacy Residency, University of Missouri at Kansas City & Truman Medical Center-1984-1985

Licensures:

North Dakota #4039, 1982-present
Texas #26472, 1982-present
Oklahoma #10622, 1985-1998
South Dakota #R-4837, 1994-1998

Certifications:

Board Certified Pharmacotherapy Specialist
Board of Pharmaceutical Specialties
BCPS# 2 91 149
October 1, 1991-1998, Recertified by Examination 1998-2005, 2005-2012, 2012-2019.

HONORS AND AWARDS

Leadership Award

Inducted into Phi Lambda Sigma Pharmacy Leadership Society Beta Pi Chapter, March 4, 2006.

Teaching Awards

1. Nominated for the 2012-2013 TTUHSC School of Pharmacy Lubbock Faculty Preceptor of the Year
2. Nominated for the 2011-2012 TTUHSC School of Pharmacy Lubbock Faculty Preceptor of the Year
3. Nominated for the 2010-2011 ACCP Adult Medicine PRN Mentor of the Year Award
4. TTUHSC School of Pharmacy 2008-2009 P3 Teaching Team of the Year (Nutrition)
5. TTUHSC School of Pharmacy 2007-2008 Lubbock Faculty Preceptor of the Year
6. Nominated for the 2006-2007 TTUHSC School of Pharmacy Lubbock Faculty Preceptor of the Year
7. Nominated for the 2002-2003 TTUHSC School of Pharmacy Lubbock P3 Preceptor of the Year
8. Nominated for the 2001-2002 TTUHSC School of Pharmacy Outstanding P4 faculty member of the Year
9. TTUHSC School of Pharmacy 2000-2001 Lubbock P4 Preceptor of the Year
10. TTUHSC Lubbock Student Senate 1999-2000 Teacher of the Year Award for Pharmacy
11. Nominated for the 1999-2000 TTUHSC School of Pharmacy Lubbock P4 Preceptor of the Year
12. TTUHSC School of Pharmacy 1999 P3 Instructional Team of the Year (Oncology Pharmacotherapy)
13. Academic Teaching Excellence Award for Exemplary Didactic Instruction in the Doctor of Pharmacy Program, OUHSC College of Pharmacy, 1993.
14. Finalist for OUHSC College of Pharmacy Alumni's Teaching Excellence Award for 1990-91.
15. Kappa Psi Pharmaceutical Fraternity Gamma Omicron Chapter's Outstanding Professor for 1989-90.
16. Finalist for OUHSC College of Pharmacy Alumni's Teaching Excellence Award for 1989-90.
17. Kappa Psi Pharmaceutical Fraternity Gamma Omicron Chapter's Outstanding Professor for 1986-87.
18. Finalist for OUHSC College of Pharmacy Alumni's Teaching Excellence Award for 1986-87.

Practice Award

Texas Society of Health-System Pharmacists 2009 Innovative Collaborative Practice Award with TTUHSC Pharmacy, F. Marie Hall Institute for Rural & Community Health, and Ontai Family Medicine for Developing the 1st Functioning Telepharmacy in Texas.

Research Awards

1. Outstanding Resident Poster Award ($100), ACCP Adult Medicine PRN, Brown AT, Seifert CF. Effect of treatment variation on outcomes in patients with Clostridium difficile associated diarrhea. 2012 ACCP Annual Meeting, Hollywood, Florida, October 22, 2012.
2. Selected as Platform Presentation, Brown AT, Seifert CF. Effect of treatment variation on outcomes in patients with Clostridium difficile associated diarrhea. 11th Annual TTUHSC School of Pharmacy Research Days, Amarillo, Texas, June 13, 2012.
3. Selected as Platform Presentation, Villarreal SM, Seifert CF, Zepeda Z, Torres C, Cobos E. An evaluation of ambulatory pain control in patients with solid tumor malignancies. 10th Annual TTUHSC School of Pharmacy Research Days, Amarillo, Texas, June 15, 2011.
4. Selected as Platform Presentation, Villagran G, Seifert CF. Clopidogrel and proton pump inhibitor Co-prescribing (CLAP COP) study. 9th Annual TTUHSC School of Pharmacy Research Days, Amarillo, Texas, June 16, 2010.
5. Outstanding Poster Presentation, 2nd Place, Resident Category, 7th Annual TTUHSC School of Pharmacy Research Days, Simoni P, Cunningham A, Simoni J, Kilpatrick A, Cox S, Seifert CF. Urinary Markers for Renal Damage in Patients Undergoing Cardiac Catheterization Receiving Contrast Dye. Amarillo, Texas, June 4, 2008.
6. Outstanding Poster Presentation, Resident Category, 3rd Annual TTUHSC School of Pharmacy Research Days, Mazzolini TA, Irons BK, Seifert CF. Assessment of the Level of Care Provided by Pharmacist-Managed Lipid Referral Clinics Compared to Usual Care in Patients with Dyslipidemia. Amarillo, Texas, July 29, 2004.
7. Outstanding Poster Presentation, Resident Category, 2nd Annual TTUHSC School of Pharmacy Research Days, Seifert CF, Kennedy SM. Evaluation of Meperidine Usage Patterns and the Incidence of Adverse Effects, Amarillo, Texas, June 3, 2003.
8. Outstanding Poster Presentation, Clinical Category ($250.00), 53rd Annual TSHP Meeting, Seifert CF, Johnston BA, Rojas-Fernandez C. A Survey of Texas Long-Term Care Facilities to Determine the Characteristics of Medication Administration through Enteral Feeding Catheters, Austin, Texas, April 2, 2001.
9. Upjohn Excellence in Research Award ($500.00), for Outstanding Doctor of Pharmacy Project 1993, Seifert CF, Frye JL, Belknap DC, Anderson DC. A Nursing Survey to Determine the Characteristics of Medication Administration through Enteral Feeding Catheters, presented on May 21, 1993.
10. Outstanding Presentation, Seifert CF, Lucas DS, Vondracek TG, Kastens DJ, McCarty DL, Bui B. Acetaminophen use and hepatotoxicity in alcoholic patients. 18th Annual Midwest Residents Conference, Oklahoma City, Oklahoma, April 25, 1992.
11. Oklahoma Society of Hospital Pharmacists Excellence in Research Award ($500.00), Splinter MY, Seifert CF, Bradberry JC, Allen LV, Tu YH, Welsh JD, Recovery of Phenytoin Suspension after In Vitro Administration through Percutaneous Endoscopic Gastrostomy Pezzar Catheters, presented at the OSHP Annual Meeting on April 22, 1989.
12. Provost's Award for Applied Research ($125.00), Splinter MY, Seifert CF, Bradberry JC, Allen LV, Tu YH, Welsh JD, Recovery of Phenytoin Suspension after In Vitro Administration through Percutaneous Endoscopic Gastrostomy Pezzar Catheters, Graduate Education and Research Day-1988, presented on March 31, 1988.

Service Awards

1. Founding Senator Award, Texas Tech University Health Sciences Center Faculty Senate, Presented on April 9, 2008.
2. Selected as one of 25 pharmacists in the country to participate in a Pilot Program with the American Society of Health-System Pharmacists Clinical Skills Development Series for Promoting Pharmaceutical Care, Bethesda, Maryland, April 10, 1995, $2500.00.
3. Fellowship in the American College of Clinical Pharmacy (the highest honor the College can bestow), inducted on August 2, 1994.
4. Grand Regent Letter of Commendation and Award for wise counsel to Gamma Omicron Chapter of Kappa Psi Pharmaceutical Fraternity presented on April 24, 1992.
5. Certificate of Commendation for wise counsel to Gamma Omicron Chapter of Kappa Psi Pharmaceutical Fraternity presented on June 20, 1989.
6. Oklahoma Society of Hospital Pharmacists Continuing Excellence Award for advancing the profession of pharmacy through professional and community service, Presented at the OSHP Annual Meeting on April 22, 1989.
7. Oklahoma Society of Hospital Pharmacists Continuing Excellence Award for advancing the profession of pharmacy through professional and community service, Presented at the OSHP Annual Meeting on May 21, 1988.
8. Outstanding Young Men of America, 1987.

Scholarship Awards

1. Phi Kappa Phi Honor Society-NDSU-1981.
2. Rho Chi Pharmaceutical Honor Society-Kappa Chapter-NDSU-1981.
3. Searle Award for Excellence in Pharmacology-NDSU-1981.
4. Who's Who Among American College Students-NDSU-1981.

Publications:

Refereed Journals

1. Irons BK, Simoni J, Meyerrose GE, Trujillo A, Seifert CF. Effects of Direct Renin Inhibition on Atherosclerotic Biomarkers in Patients with Stable Coronary Artery Disease and Type 2 Diabetes Mellitus. Journal of Cardiovascular Pharmacology and Therapeutics 2013; In Press. (original research)
2. Edgar AL, Seifert CF. Timing and Appropriateness of Initial Antibiotic Therapy in Newly Presenting Septic Patients. American Journal of Emergency Medicine 2013; In Press. (original research)
3. Edgar AL, Limsuwat C, Williams DR, Seifert CF. Cholestatic Jaundice as a Result of Combination Designer Supplement Ingestion. Annals of Pharmacotherapy 2013; In Press. (case report with critical review)
4. Cox CD, Peeters MJ, Seifert CF. Pilot of Peer Assessment within Experiential Teaching & Learning. Currents in Pharmacy Teaching and Learning 2013; In Press. (original research)
5. Robles J, Cox CD, Seifert CF. Evaluation of Preceptor and Student Learning Styles and Their Impact on Experiential Performance Measures. American Journal of Pharmaceutical Education 2012;76 (7) Article 128. (original research)
6. Irons BK, Laguardia S, Meyerrose G, Kweku H, Seifert CF. A Collaborative Cardiologist-Pharmacist Care Model to Improve Hypertension Management in Patients with or at High Risk for Cardiovascular Disease. Pharmacy Practice 2012;10:25-32. (original research)
7. MacLaughlin EJ, Fike DS, Alvarez CA, Seifert CF, Blaszcyk AT. Reliability of a seminar grading rubric in a grand rounds course. J Multidisc Healthcare 2010;3:169-79. (original research)
8. Crowder RS, Irons BK, Meyerrose G, Seifert CF. Factors associated with increased hospital utilization in patients with heart failure and preserved ejection fraction. Pharmacotherapy 2010;30:646-53. (original research)
9. Loan TR, Cox CD, Seifert CF. Evaluation of prescribing patterns of 5HT3 receptor antagonists (5HT3 RA’s) on general medicine floors. TSHP Journal 2009;10:24-27. (original research)
10. Irons BK, Flemming B, Seifert CF, Wesson DE. Evaluation of diabetes primary care and effects on health care charges in elderly diabetics. The American Journal of the Medical Sciences 2008;335:426-30. (original research)
11. Irons BK, Seifert CF, Horton NA. Quality of care of a pharmacist-managed diabetes service compared to usual care in an indigent clinic. Diabetes Technology and Therapeutics 2008;10:220-26. (original research).
12. Peeters MJ, Seifert CF. Agreement with antimicrobial management for Pseudomonal ventilator-associated pneumonia. [letter] Critical Care Medicine 2007;35:2882.
13. Seifert CF, Anderson DC. Acetaminophen usage patterns, plasma glutathione and gamma glutamyl transferase in alcoholics. Pharmacotherapy 2007;27:1473-82. (original research)
14. McNatty D, Cox CD, Seifert CF. Assessment of teaching experiences completed during accredited pharmacy residency programs. American Journal of Pharmaceutical Education 2007;71 (5) Article 88. (original research)
15. Singh S, Sleeper RB, Seifert CF. Propoxyphene prescribing among populations aged =65 vs <65 in a tertiary care hospital. The Consultant Pharmacist 2006;22:141-48. (original research)
16. Peeters MJ, Seifert CF. The use of combination antimicrobials in critically-ill ventilated patients with pseudomonal pneumonia. Hospital Pharmacy 2006;41;848-54. (original research).
17. Tsikouris JP, Cox CD, Simoni J, Seifert CF, Lorvidhaya P, Peek MC, Meyerrose GE. Lack of effect on coronary atherosclerotic disease biomarkers with modest dosing of an ACE inhibitor, angiotensin II type-I receptor blocker, and the combination. Coronary Artery Disease 2006;17:439-46. (original research).
18. Tsikouris JP, Peeters MJ, Cox CD, Meyerrose GE, Seifert CF. Effects of three fluoroquinolones on QT analysis after standard treatment courses. Annals of Noninvasive Electrocardiology 2006;11:52-56. (original research).
19. Mazzolini TA, Irons BK, Schell EC, Seifert CF. Lipid levels and use of lipid-lowering drugs for patients in pharmacist-managed lipid clinics versus usual care in 2 VA Medical Centers. Journal of Managed Care Pharmacy 2005;11:763-71. (original research)
20. Seifert CF, Johnston BA. A nationwide survey of long-term care facilities to determine the characteristics of medication administration through enteral feeding catheters. Nutrition in Clinical Practice 2005;20:354-62. (original research)
21. Mazzolini TA, Irons BK, Seifert CF. Assessment of level of care in patients with type 2 diabetes mellitus in an outpatient indigent clinic. TSHP Journal 2005;6:7-14. (original research)
22. Seifert CF, Veronin MA, Kretschmer TD, McBeath DB, Stanford SJ, Turner D, Ontai SC. The training of a Telepharmacist: Addressing the needs of rural west Texas. American Journal of Pharmaceutical Education 2004;68 Article 60:1-9. (original research)
23. Seifert CF, Kennedy S. Meperidine is alive and well in the new millennium: Evaluation of meperidine usage patterns and frequency of adverse drug reactions. Pharmacotherapy 2004;24:776-83. (original research)
24. Tsikouris JP, Jackson II KC, Fike DS, Cox CD, Meyerrose GE, Seifert CF. Thrombolytic fibrin specificity influences activated partial thromboplastin time prolongation in vitro. Blood Coagulation and Fibrinolysis 2002;13:725-31. (original research)
25. Seifert CF, Johnston BA, Rojas-Fernandez C. Drug administration through enteral feeding catheters. American Journal of Health-System Pharmacists 2002;59:378-79. (original research).
26. Seifert CF, Johnston BA, Rojas-Fernandez C. A Survey of Texas Long-Term Care Facilities to Determine the Characteristics of Medication Administration through Enteral Feeding Catheters. TSHP Journal 2001;2:40-48. (original research)
27. Horlen CK, Seifert CF, Malouf CS. Toxic Metronidazole-Induced MRI Changes. Annals of Pharmacotherapy 2000;34:1273-75 (case report with critical review).
28. Belknap DC, Seifert CF, Petermann M. Administration of Medications through Enteral Feeding Catheters. American Journal of Critical Care 1997;6:382-92 (original research).
29. Seifert CF, Frye JL, Belknap DC, Anderson DC. A Nursing Survey to Determine the Characteristics of Medication Administration through Enteral Feeding Catheters. Clinical Nursing Research 1995;4:290-305 (original research).
30. Seifert CF, Nesser ME, Thompson DF. Dexrazoxane in the Prevention of Doxorubicin-Induced Cardiotoxicity. Annals of Pharmacotherapy 1994;28:1063-72 (critical review).
31. Anderson DC, Seifert CF. Topical Nitrate Treatment of Impotence. Annals of Pharmacotherapy 1993;27:1203-05 (case report with critical review).
32. Howard CD, Seifert CF. Flumazenilo en el Tratamiento de la Encefalopatia Hepatica. Annals of Pharmacotherapy (Ed. Esp.) 1993;1:207-09 (critical review).
33. Seifert CF, Lucas DS, Vondracek TG, Kastens DJ, McCarty DL, Bui B. Acetaminophen Usage Patterns in Alcoholic Patients. Pharmacotherapy 1993;13:391-95 (original research).
34. Seifert CF, McGoodwin PL, Allen LV. Phenytoin Recovery from Percutaneous Endoscopic Gastrostomy Pezzar Catheters Following Chronic In Vitro Administration. Journal of Parenteral and Enteral Nutrition 1993;17:370-74 (original research).
35. Howard CD, Seifert CF. Flumazenil in the Treatment of Hepatic Encephalopathy. Annals of Pharmacotherapy 1993;27:46-48 (critical review).
36. Vondracek TG, Seifert CF. Use of ursodiol in a patient with biliary cirrhosis. Clinical Pharmacy 1992;11:672-73 (critical review).
37. Harmon SM, Seifert CF. Levothyroxine-Cholestyramine Interaction Reemphasized [letter]. Annals of Internal Medicine 1991;115:658-59.
38. Seifert CF, Stanaszek WF. Arthritis in the Elderly: Update 1990. Journal of Geriatric Drug Therapy 1990;4: 7-42 (critical review).
39. Small Wright P, Seifert CF, Hampton EM. Toxic Carbamazepine Concentrations Following Cardiothoracic Surgery and Myocardial Infarction. DICP, Annals of Pharmacotherapy 1990;24:822-26 (case report with critical review).
40. Splinter MY, Seifert CF, Bradberry JC, Tu YH, Allen LV. The Effect of pH on the Equilibrium Dialysis of Phenytoin Suspension with and without Enteral Feeding Formula. Journal of Parenteral and Enteral Nutrition 1990;14:275-78 (original research).
41. Splinter MY, Seifert CF, Bradberry JC, Allen LV, Tu YH, Welsh JD. Recovery of Phenytoin Suspension after In Vitro Administration through Percutaneous Endoscopic Gastrostomy Pezzar Catheters. American Journal of Hospital Pharmacy 1990;47:373-77 (original research).
42. Stanaszek WF, Seifert CF. Arthritis in the Elderly: Presentation, Treatment, and Monitoring Aspects. Journal of Geriatric Drug Therapy 1989;3:5-89 (critical review).
43. Seifert CF, Swaney RJ, Bellanger-McCleery RA. Intravenous Erythromycin Lactobionate Induced Severe Nausea and Vomiting. DICP, Annals of Pharmacotherapy 1989; 23: 40-44 (case report with critical review).
44. Seifert CF, Hamilton SF. Incorrect Aerosolized Bronchodilator Administration [letter]. American Journal of Hospital Pharmacy 1988;45:75-76.
45. Seifert CF, Covinsky JO, Burke JM, Hamburger S. Decreased Theophylline Clearance in a Patient with Severe Hypothyroidism. Drug Intelligence and Clinical Pharmacy 1987;21:442-45 (case report with critical review).
46. Zuerker JC, Bradberry JC, Seifert CF, Welsh JD, Rankin RA. Medications for Use in Patients with Enteral Feeding Tubes [letter]. Gastrointestinal Endoscopy 1987;33:271.
47. Zuerker JC, Bradberry JC, Seifert CF, Welsh JD, Rankin RA. Medications for use in Patients with Enteral Feeding Tubes [letter]. Gastrointestinal Endoscopy 1987;33:127.
48. Zee-Cheng CS, Mueller CE, Seifert CF, Gibbs HR. Haloperidol and Torsades de Pointes [letter]. Annals of Internal Medicine 1985;102:418.

Book Chapters

49. Seifert CF, Resman-Targoff BH. Clinical Laboratory Tests and Interpretation. In Helms RA, Quan DJ, Herfindal ET, Gourley DR, eds. Textbook of Therapeutics: Drug and Disease Management 8th Ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2006, 91-115.
50. Seifert CF, Resman-Targoff BH. Clinical Laboratory Tests and Interpretation. In Gourley DR, Herfindal ET, eds. Textbook of Therapeutics: Drug and Disease Management 7th. Ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2000, pp 69-91.
51. Seifert CF. Section 1 General, Case 4. In: Schroeder DJ, Gourley DR, Herfindal ET, eds. Casebook for Herfindal and Gourley's Textbook of Therapeutics Drug and Disease Management Baltimore, MD: Williams & Wilkins;1996, pp.5-6.
52. Seifert CF, Bradberry JC, Resman-Targoff BH. Clinical Laboratory Tests and Interpretation. In Herfindal ET, Gourley DR, eds. Textbook of Therapeutics: Drug and Disease Management 6th. ed. Baltimore, MD: Williams & Wilkins; 1996;61-81.
53. Seifert CF. Section 1 General, Cases 1, 2, 8, & 14. In: Lloyd Hart L, Herfindal ET, Gourley DR, eds. Clinical Pharmacy and Therapeutics Workbook 2nd ed. Baltimore, MD: Williams & Wilkins; 1992, pp. 1-3, 10, 14.
54. Seifert CF, Bradberry JC, Resman-Targoff BH. Clinical Laboratory Tests and Interpretation. In: Herfindal ET, Gourley DR, Lloyd Hart L, eds. Clinical Pharmacy and Therapeutics 5th ed. Baltimore, MD: Williams & Wilkins; 1992, pp. 61-81.
55. Seifert CF. Cited in Medications: Science to the Rescue, Chapter 26, In: Feinstein A. ed. The Prevention Pain-Relief System 1st ed. Emmaus, PA: Rodale Press, Inc.; 1992, pp. 471-93.

Web Sites

56. Seifert CF, Johnston BA, Brown RO, DeLegge MH, Dell KA, Lord LM, Lyman B, Rollins CJ. Consensus Recommendations for Administering Medications through an Enteral Feeding Tube. 2004; http://www.ttuhsc.edu/centers/aging/staff/charlesSeifert.aspx.

Drugdex Consults (Peer Reviewed Drug Information Consults)

57. Seifert CF, Elenbaas JK. Therapy of Psychiatric Disturbances in Parkinsonian Patients. In: Conner CS, Rumack BH, eds. Drugdex Information System Englewood, CO: Micromedex, Inc., 1984.
58. Seifert CF, Elenbaas JK. Menopausal Symptoms-Non Estrogenic Drug Therapy. In: Conner CS, Rumack BH, eds. Drugdex Information System Englewood, CO: Micromedex, Inc., 1984.
59. Seifert CF, Knodel LC. Methotrexate/Corticosteroids-Intrathecal Administration. In: Conner CS, Rumack BH, eds. Drugdex Information System. Englewood, CO: Micromedex, Inc., 1984.
60. Seifert CF, Knodel LC. Therapy of Migraine Headache During Pregnancy. In: Conner CS, Rumack BH, eds. Drugdex Information System. Englewood, CO: Micromedex, Inc., 1984.

Non-Refereed Journals

61. Seifert CF. General Principles of Acute Poisonings. South Dakota Journal of Medicine 1996;49:465-66.
62. Seifert CF. Cited In: Sterne D. Cholesterol Update. 10 Most Often Asked Questions.....and the Answers. Drug Topics 1990;134 (7):38-46.
63. Seifert CF, Stanaszek WF. Management of Minor Pain with OTC Medications. NARD Journal 1990; 112 (1):53-56.
64. Seifert CF. Cited In: Starr C. Saying No to Cholesterol (Part 2). Drug Topics 1989;133 (6):19-22.
65. Seifert CF. Cited In: Starr C. Saying No to Cholesterol (Part 1). Drug Topics 1989;133 (5):39-52.
66. Seifert CF. Cited In: Starr C. What Pharmacists can do to cut Cholesterol Levels. Drug Topics 1988;132:22.
67. Seifert CF. Dilemmas in Drug Usage: Chronic Bacterial Prostatitis. Hospital Therapy 1987;12:81-94.
68. Seifert CF, Cuddy PG, Pemberton LB, Lyman EM, Schmitt P. A Randomized Trial of Metoclopramide's Effects on the Transpyloric Intubation of Weighted Feeding Tubes. Nutritional Support Services 1987;7:11-13.
69. Seifert CF. Dilemmas in Drug Usage: Wolff-Parkinson-White Syndrome. Hospital Therapy 1986;11:26-35.

Peer Reviewed Abstracts

70. Brown AT, Seifert CF. Effect of treatment variation on outcomes in patients with Clostridium difficile associated diarrhea. (#323) Pharmacotherapy 2012:32:e273.
71. Laguardia SV, Irons BK, Meyerrose G, Seifert CF. Outcomes of a pharmacist-cardiologist collaborative care model in hypertension management in patients with cardiovascular disease. (#16) Pharmacotherapy 2010;30:370e.
72. Villagran G, Seifert CF. Clopidogrel and proton pump inhibitor co-prescribing study. (#2) Pharmacotherapy 2010;30:366e.
73. MacLaughlin EJ, Fike DS, Alvarez CA, Seifert CF, Blaszczyk AT. Reliability of a seminar grading rubric in a grand rounds course. (#45) Pharmacotherapy 2009;29:195e.
74. Loan TR, Seifert CF. Heel ultrasonography in young healthy adults prescribed selective serotonin reuptake inhibitors. (#271) Pharmacotherapy 2009;29:259e-60e.
75. Simoni P, Cunningham A, Simoni J, Kilpatrick A, Cox S, Seifert CF. Urinary markers for renal damage in patients undergoing cardiac catheterization receiving contrast dye. (#284) Pharmacotherapy 2008;28:198e-199e.
76. Cox CD, Tsikouris JP, Peek MC, Seifert CF. An evaluation of ACE-inhibitors in contrast nephropathy. (#205) Pharmacotherapy 2005;25:1464.
77. Peeters MJ, Seifert CF. Antimicrobial use in critically-ill ventilated patients with pseudomonal pneumonia. (#61) Pharmacotherapy 2005;25:1440.
78. Grabe DW, Seifert CF. Characteristics of therapeutic monitoring of phenytoin in dialysis centers: a nationwide survey. (#44) American Journal of Kidney Diseases 2005;45:A27.
79. Seifert CF, Johnston BA. A comparison between ICU and LTCF nurses in delivering medications through enteral feeding catheters. (#193) Pharmacotherapy 2004;24:1450.
80. Peeters MJ, Tsikouris JP, Cox CD, Meyerrose GE, Seifert CF. Evaluating the risk of Torsades de pointes with fluoroquinolones: an analysis of QT-interval and QT-dispersion. (#26) Pharmacotherapy 2004;24:1424.
81. Cox CD, Stanford BL, Brouse S, Haase KK, Akins RL, Bowie VL, Tsikouris JP, Busti AJ, Shah S, Hall R, Burleson B, Seifert CF. Validation of an experiential teaching peer assessment tool. (#62) Pharmacotherapy 2004;24:1430.
82. Mazzolini TA, Irons BK, Sorrells EC, Seifert CF. Assessment of the level of care provided by pharmacist-managed lipid referral clinics compared to usual care in patients with dyslipidemia. TSHP Journal 2004;5:40.
83. Cox CD, Tsikouris JP, Peeters MJ, Meyerrose GE, Seifert CF. Evaluating the risk of torsades de pointes with various fluoroquinolones: An analysis of QT-interval prolongation and QT-dispersion. TSHP Journal 2004;5:30.
84. Cox CD, Tsikouris JP, Peeters MJ, Meyerrose GE, Seifert CF. Evaluating the risk of torsades de pointes with various fluoroquinolones: An analysis of QT-interval prolongation and QT-dipsersion. (PL II-2) TSHP Journal 2004;5:26.
85. Cox CD, Stanford BL, Brouse S, Seifert CF, Haase KK, Akins RL, Bowie VL, Tsikouris JP, Busti AJ, Shah S, Hall R. Development of an experiential assessment tool. (#57) Pharmacotherapy 2003;23:1336.
86. Seifert CF, Veronin MA, Patry RA, McBeath DB, Phillips JC, Ontai SC, Kretschmer TD, Patterson PJ. Telepharmacy from classroom to practice: a pilot study. (#58) Pharmacotherapy 2003;23:1336-37.
87. Seifert CF, Johnston BA. A nationwide survey of long-term care facilities to determine the characteristics of medication administration through enteral feeding catheters. (#161) Pharmacotherapy 2003;23:1351.
88. Seifert CF, Kennedy S. Evaluation of meperidine usage patterns and adverse reactions. (PL VIII-3) TSHP Journal 2003;4:62.
89. Tsikouris JP, Jackson II, KC, Cox CD, Meyerrose GE, Diaz JA, Seifert CF. Thrombolytic fibrin specificity influences activated partial thromboplastin time prolongation. (1192-33) Journal of the American College of Cardiology 2002;39:331A-332A.
90. Seifert CF, Johnston BA, Rojas-Fernandez C. A survey of Texas long-term care facilities to determine the characteristics of medication administration through enteral feeding catheters. (C-6) TSHP Journal 2001;2:71-72.
91. Nguyen UL, Reilly JC, Seifert CF. Documentation of the influence of clinical pharmacists at a county hospital through the use of personal digital assistants. (PL IV-2) TSHP Journal 2001;2:27.
92. Stallworth KL, Seifert CF. Evaluation of aminoglycoside and vancomycin usage patterns for implementation of therapeutic drug monitoring services. (PL IV-6) TSHP Journal 2001:2:28.
93. Seifert CF, Johnston BA, Rojas-Fernandez C. A survey of Texas long-term care facilities to determine the characteristics of medication administration through enteral feeding catheters. (#85) Pharmacotherapy 2000;20:1243.
94. Klementich FJ, Seifert CF. Treatment of Type 2 Diabetes Mellitus in a Medically Indigent Population. ALCALDE XIV Southwest Leadership Conference for Pharmacy Residents, Fellows & Preceptors, Platform Presentation, San Antonio, Texas, March 17, 2000, PL II-1.
95. Horlen CK, Seifert CF. Estimated Cost-Savings of Implementing an Anticoagulation Clinic for the Medically Indigent. ALCALDE XIV Southwest Leadership Conference for Pharmacy Residents, Fellows, & Preceptors, Platform Presentation, San Antonio, Texas, March 17, 2000, PL III-7.
96. Seifert CF, Anderson DC, Bui B, Glore SR, Vondracek TG, Raymond T. Correlation of acetaminophen, ethanol, and cocaine use, plasma glutathione concentrations, and diet with hepatotoxicity. (#193) Pharmacotherapy 1994;14:376-77.
97. Seifert CF, Frye JF, Belknap DC, Anderson DC. A Nursing Survey to Determine the Characteristics of Medication Administration through Enteral Feeding Catheters. (#49) Pharmacotherapy 1993;13:275.
98. McGoodwin PL, Seifert CF, Bradberry JC, Allen LV. Recovery of Phenytoin from a Percutaneous Endoscopic Gastrostomy Pezzar Catheter Following In Vitro Delivery of Multiple Doses of Phenytoin Suspension and Phenytoin Capsules. American Society of Hospital Pharmacists 25th Annual Midyear Clinical Meeting, Las Vegas, Nevada, December 2-6, 1990, SPG-53, pp. 226.
99. Small Wright P, Seifert CF, Hampton EM. Toxic Carbamazepine Concentrations Following Cardiothoracic Surgery and Myocardial Infarction. Clinical Abstracts 1990;9:68.
100. McGoodwin PL, Seifert CF, Bradberry JC, Allen LV. Recovery of Phenytoin from a Percutaneous Endoscopic Gastrostomy Pezzar Catheter Following In Vitro Delivery of Multiple Doses of Phenytoin Suspension and Phenytoin Capsules. (#152) Pharmacotherapy 1990;10:254.
101. Splinter MY, Seifert CF, Bradberry JC, Tu YH, Allen LV. The Effect of pH on the Equilibrium Dialysis of Phenytoin Suspension with and without Enteral Feeding Solution. (#128) Pharmacotherapy 1988;8:136.
102. Seifert CF, Swaney RJ, Bellanger-McCleery RA. Intravenous Erythromycin Lactobionate Induced Severe Nausea and Vomiting. Clinical Abstracts 1988;7: 23-24.
103. Splinter MY, Seifert CF, Bradberry JC, Allen LV, Tu YH, Welsh JD. The Gastric Availability of Phenytoin Suspension Through a Percutaneous Endoscopic Gastrostomy Pezzar Catheter, American Society of Hospital Pharmacists 22nd Annual Midyear Clinical Meeting, Atlanta, Georgia, December 6-10, 1987, P-347 E, pp. 113-14.
104. Seifert CF. Monotherapy for Essential Hypertension. American Society of Hospital Pharmacists 43rd Annual Meeting, Denver, Colorado, June 2-5 1986;S-33: 128-29.